nodes	percent_of_prediction	percent_of_DWPC	metapath
Spironolactone—Hydrocortisone—psoriasis	0.314	1	CrCtD
Spironolactone—CYP11B2—Hydrocortisone—psoriasis	0.0285	0.0842	CbGbCtD
Spironolactone—NR3C1—Clobetasol propionate—psoriasis	0.027	0.0799	CbGbCtD
Spironolactone—NR3C2—Betamethasone—psoriasis	0.0212	0.0627	CbGbCtD
Spironolactone—NR3C2—Prednisolone—psoriasis	0.0209	0.0619	CbGbCtD
Spironolactone—NR3C1—Fluocinonide—psoriasis	0.0205	0.0606	CbGbCtD
Spironolactone—NR3C1—Beclomethasone—psoriasis	0.0205	0.0606	CbGbCtD
Spironolactone—NR3C1—Fluocinolone Acetonide—psoriasis	0.0205	0.0606	CbGbCtD
Spironolactone—CYP11B1—Hydrocortisone—psoriasis	0.0185	0.0547	CbGbCtD
Spironolactone—PGR—Betamethasone—psoriasis	0.0137	0.0405	CbGbCtD
Spironolactone—Fluoxymesterone—Clobetasol propionate—psoriasis	0.0136	0.0479	CrCrCtD
Spironolactone—Fludrocortisone—Clobetasol propionate—psoriasis	0.0132	0.0467	CrCrCtD
Spironolactone—Hydrocortamate—Beclomethasone—psoriasis	0.0126	0.0444	CrCrCtD
Spironolactone—NR3C2—Dexamethasone—psoriasis	0.0123	0.0365	CbGbCtD
Spironolactone—SHBG—Hydrocortisone—psoriasis	0.0123	0.0364	CbGbCtD
Spironolactone—Eplerenone—Hydrocortisone—psoriasis	0.0111	0.0392	CrCrCtD
Spironolactone—Fludrocortisone—Fluocinolone Acetonide—psoriasis	0.0103	0.0364	CrCrCtD
Spironolactone—Dydrogesterone—Hydrocortisone—psoriasis	0.00884	0.0312	CrCrCtD
Spironolactone—Drospirenone—Hydrocortisone—psoriasis	0.00884	0.0312	CrCrCtD
Spironolactone—Potassium Canrenoate—Hydrocortisone—psoriasis	0.00842	0.0297	CrCrCtD
Spironolactone—NR3C1—Triamcinolone—psoriasis	0.00816	0.0241	CbGbCtD
Spironolactone—PGR—Dexamethasone—psoriasis	0.00797	0.0236	CbGbCtD
Spironolactone—Megestrol acetate—Hydrocortisone—psoriasis	0.0077	0.0272	CrCrCtD
Spironolactone—CYP2C8—Tazarotene—psoriasis	0.00758	0.0224	CbGbCtD
Spironolactone—Potassium Canrenoate—Prednisone—psoriasis	0.00725	0.0256	CrCrCtD
Spironolactone—Potassium Canrenoate—Prednisolone—psoriasis	0.00708	0.025	CrCrCtD
Spironolactone—NR3C1—Betamethasone—psoriasis	0.007	0.0207	CbGbCtD
Spironolactone—NR3C1—Prednisolone—psoriasis	0.0069	0.0204	CbGbCtD
Spironolactone—Medroxyprogesterone Acetate—Hydrocortisone—psoriasis	0.00685	0.0242	CrCrCtD
Spironolactone—NR3C1—Hydrocortisone—psoriasis	0.00654	0.0194	CbGbCtD
Spironolactone—NR3C1—Prednisone—psoriasis	0.00652	0.0193	CbGbCtD
Spironolactone—Hydrocortamate—Hydrocortisone—psoriasis	0.00619	0.0218	CrCrCtD
Spironolactone—Cortisone acetate—Hydrocortisone—psoriasis	0.00599	0.0211	CrCrCtD
Spironolactone—SLCO1A2—Prednisolone—psoriasis	0.00595	0.0176	CbGbCtD
Spironolactone—ABCC2—Mycophenolate mofetil—psoriasis	0.00583	0.0172	CbGbCtD
Spironolactone—SLCO1A2—Hydrocortisone—psoriasis	0.00564	0.0167	CbGbCtD
Spironolactone—SLCO1A2—Prednisone—psoriasis	0.00562	0.0166	CbGbCtD
Spironolactone—Testolactone—Dexamethasone—psoriasis	0.0054	0.019	CrCrCtD
Spironolactone—Testolactone—Betamethasone—psoriasis	0.0054	0.019	CrCrCtD
Spironolactone—Fluoxymesterone—Hydrocortisone—psoriasis	0.00535	0.0188	CrCrCtD
Spironolactone—Hydrocortamate—Prednisone—psoriasis	0.00533	0.0188	CrCrCtD
Spironolactone—SLCO1A2—Cyclosporine—psoriasis	0.00533	0.0157	CbGbCtD
Spironolactone—Testolactone—Triamcinolone—psoriasis	0.00528	0.0186	CrCrCtD
Spironolactone—Progesterone—Hydrocortisone—psoriasis	0.00521	0.0184	CrCrCtD
Spironolactone—Testosterone Propionate—Hydrocortisone—psoriasis	0.00521	0.0184	CrCrCtD
Spironolactone—Fludrocortisone—Hydrocortisone—psoriasis	0.00521	0.0184	CrCrCtD
Spironolactone—Hydrocortamate—Prednisolone—psoriasis	0.0052	0.0183	CrCrCtD
Spironolactone—Cortisone acetate—Prednisone—psoriasis	0.00516	0.0182	CrCrCtD
Spironolactone—Methyltestosterone—Hydrocortisone—psoriasis	0.00508	0.0179	CrCrCtD
Spironolactone—Cortisone acetate—Prednisolone—psoriasis	0.00504	0.0178	CrCrCtD
Spironolactone—Testolactone—Prednisone—psoriasis	0.00501	0.0177	CrCrCtD
Spironolactone—Fluoxymesterone—Betamethasone—psoriasis	0.00497	0.0175	CrCrCtD
Spironolactone—Fluoxymesterone—Dexamethasone—psoriasis	0.00497	0.0175	CrCrCtD
Spironolactone—Testolactone—Prednisolone—psoriasis	0.00489	0.0172	CrCrCtD
Spironolactone—Fluoxymesterone—Triamcinolone—psoriasis	0.00485	0.0171	CrCrCtD
Spironolactone—Fludrocortisone—Betamethasone—psoriasis	0.00484	0.017	CrCrCtD
Spironolactone—Fludrocortisone—Dexamethasone—psoriasis	0.00484	0.017	CrCrCtD
Spironolactone—Fludrocortisone—Triamcinolone—psoriasis	0.00473	0.0167	CrCrCtD
Spironolactone—Testosterone—Hydrocortisone—psoriasis	0.00452	0.0159	CrCrCtD
Spironolactone—Fluoxymesterone—Prednisolone—psoriasis	0.00449	0.0158	CrCrCtD
Spironolactone—Fludrocortisone—Prednisone—psoriasis	0.00448	0.0158	CrCrCtD
Spironolactone—ABCC2—Cyclosporine—psoriasis	0.00442	0.0131	CbGbCtD
Spironolactone—Progesterone—Prednisolone—psoriasis	0.00438	0.0154	CrCrCtD
Spironolactone—Fludrocortisone—Prednisolone—psoriasis	0.00438	0.0154	CrCrCtD
Spironolactone—Methyltestosterone—Prednisone—psoriasis	0.00437	0.0154	CrCrCtD
Spironolactone—Methyltestosterone—Prednisolone—psoriasis	0.00427	0.015	CrCrCtD
Spironolactone—NR3C1—Dexamethasone—psoriasis	0.00407	0.012	CbGbCtD
Spironolactone—Hydrocortisone—Betamethasone—psoriasis	0.00394	0.0139	CrCrCtD
Spironolactone—Hydrocortisone—Dexamethasone—psoriasis	0.00394	0.0139	CrCrCtD
Spironolactone—Hydrocortisone—Triamcinolone—psoriasis	0.00385	0.0136	CrCrCtD
Spironolactone—Testosterone—Prednisolone—psoriasis	0.0038	0.0134	CrCrCtD
Spironolactone—Hydrocortisone—Prednisone—psoriasis	0.00366	0.0129	CrCrCtD
Spironolactone—Hydrocortisone—Prednisolone—psoriasis	0.00357	0.0126	CrCrCtD
Spironolactone—SLCO1A2—Dexamethasone—psoriasis	0.00351	0.0104	CbGbCtD
Spironolactone—CYP2C8—Cholecalciferol—psoriasis	0.00324	0.00957	CbGbCtD
Spironolactone—ABCC2—Dexamethasone—psoriasis	0.00291	0.0086	CbGbCtD
Spironolactone—SLCO1A2—Methotrexate—psoriasis	0.00282	0.00833	CbGbCtD
Spironolactone—CYP2C8—Mycophenolate mofetil—psoriasis	0.00281	0.0083	CbGbCtD
Spironolactone—ABCC2—Methotrexate—psoriasis	0.00234	0.00691	CbGbCtD
Spironolactone—CYP2C8—Hydrocortisone—psoriasis	0.00225	0.00666	CbGbCtD
Spironolactone—CYP2C8—Cyclosporine—psoriasis	0.00213	0.00629	CbGbCtD
Spironolactone—ABCB1—Mycophenolate mofetil—psoriasis	0.0019	0.00562	CbGbCtD
Spironolactone—ABCB1—Betamethasone—psoriasis	0.00163	0.00482	CbGbCtD
Spironolactone—ABCB1—Prednisolone—psoriasis	0.00161	0.00475	CbGbCtD
Spironolactone—ABCB1—Hydrocortisone—psoriasis	0.00152	0.00451	CbGbCtD
Spironolactone—ABCB1—Prednisone—psoriasis	0.00152	0.00449	CbGbCtD
Spironolactone—ABCB1—Cyclosporine—psoriasis	0.00144	0.00426	CbGbCtD
Spironolactone—CYP2C8—Dexamethasone—psoriasis	0.0014	0.00414	CbGbCtD
Spironolactone—ABCB1—Dexamethasone—psoriasis	0.000948	0.0028	CbGbCtD
Spironolactone—ABCB1—Methotrexate—psoriasis	0.000762	0.00225	CbGbCtD
Spironolactone—CYP11B1—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.000484	0.0251	CbGpPWpGaD
Spironolactone—CYP11B1—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.000478	0.0248	CbGpPWpGaD
Spironolactone—CYP11B2—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.000455	0.0236	CbGpPWpGaD
Spironolactone—CYP11B1—Corticotropin-releasing hormone—IVL—psoriasis	0.000404	0.021	CbGpPWpGaD
Spironolactone—CYP11B1—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.000392	0.0204	CbGpPWpGaD
Spironolactone—CYP2C8—Xenobiotics—CYP2S1—psoriasis	0.000359	0.0186	CbGpPWpGaD
Spironolactone—ABCB1—Allograft Rejection—IL22—psoriasis	0.000251	0.013	CbGpPWpGaD
Spironolactone—CYP11B2—Biological oxidations—CYP2S1—psoriasis	0.000242	0.0126	CbGpPWpGaD
Spironolactone—CYP11B2—Metapathway biotransformation—CYP2S1—psoriasis	0.000239	0.0124	CbGpPWpGaD
Spironolactone—AR—Coregulation of Androgen receptor activity—ZMIZ1—psoriasis	0.000238	0.0124	CbGpPWpGaD
Spironolactone—NR3C2—Nuclear Receptor transcription pathway—VDR—psoriasis	0.000228	0.0118	CbGpPWpGaD
Spironolactone—ABCC2—Drug Induction of Bile Acid Pathway—VDR—psoriasis	0.000221	0.0115	CbGpPWpGaD
Spironolactone—CYP11B1—Biological oxidations—CYP2S1—psoriasis	0.000208	0.0108	CbGpPWpGaD
Spironolactone—CYP11B1—Metapathway biotransformation—CYP2S1—psoriasis	0.000206	0.0107	CbGpPWpGaD
Spironolactone—PGR—Ovarian Infertility Genes—VDR—psoriasis	0.000202	0.0105	CbGpPWpGaD
Spironolactone—AR—Androgen receptor signaling pathway—ZMIZ1—psoriasis	0.000176	0.00915	CbGpPWpGaD
Spironolactone—PGR—Nuclear Receptors—VDR—psoriasis	0.000176	0.00913	CbGpPWpGaD
Spironolactone—AR—Regulation of Androgen receptor activity—REL—psoriasis	0.000175	0.00906	CbGpPWpGaD
Spironolactone—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—CARM1—psoriasis	0.000174	0.00903	CbGpPWpGaD
Spironolactone—AR—Regulation of Androgen receptor activity—CARM1—psoriasis	0.000172	0.00893	CbGpPWpGaD
Spironolactone—NR3C2—Nuclear Receptor transcription pathway—PPARG—psoriasis	0.000159	0.00826	CbGpPWpGaD
Spironolactone—AR—Coregulation of Androgen receptor activity—CARM1—psoriasis	0.000154	0.00798	CbGpPWpGaD
Spironolactone—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.000149	0.00774	CbGpPWpGaD
Spironolactone—CYP2C8—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.000147	0.00764	CbGpPWpGaD
Spironolactone—AR—Regulation of nuclear SMAD2/3 signaling—RUNX3—psoriasis	0.000144	0.00748	CbGpPWpGaD
Spironolactone—PGR—Nuclear Receptor transcription pathway—VDR—psoriasis	0.000139	0.00721	CbGpPWpGaD
Spironolactone—AR—Nuclear Receptors—VDR—psoriasis	0.000134	0.00695	CbGpPWpGaD
Spironolactone—NR3C1—Regulation of Androgen receptor activity—REL—psoriasis	0.000132	0.00687	CbGpPWpGaD
Spironolactone—NR3C1—Regulation of Androgen receptor activity—CARM1—psoriasis	0.00013	0.00677	CbGpPWpGaD
Spironolactone—ABCC2—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	0.000127	0.00659	CbGpPWpGaD
Spironolactone—NR3C1—Circadian Clock—CARM1—psoriasis	0.000127	0.00657	CbGpPWpGaD
Spironolactone—NR3C1—Transcription factor regulation in adipogenesis—LEP—psoriasis	0.000126	0.00654	CbGpPWpGaD
Spironolactone—PGR—Nuclear Receptors—PPARG—psoriasis	0.000123	0.00636	CbGpPWpGaD
Spironolactone—CYP2C8—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.000121	0.00628	CbGpPWpGaD
Spironolactone—AR—Integrated Breast Cancer Pathway—ZMIZ1—psoriasis	0.000115	0.00599	CbGpPWpGaD
Spironolactone—AR—Androgen receptor signaling pathway—CARM1—psoriasis	0.000114	0.0059	CbGpPWpGaD
Spironolactone—NR3C1—Transcription factor regulation in adipogenesis—PPARG—psoriasis	0.00011	0.0057	CbGpPWpGaD
Spironolactone—NR3C1—Regulation of nuclear SMAD2/3 signaling—RUNX3—psoriasis	0.000109	0.00567	CbGpPWpGaD
Spironolactone—AR—Nuclear Receptor transcription pathway—VDR—psoriasis	0.000106	0.0055	CbGpPWpGaD
Spironolactone—ABCB1—Drug Induction of Bile Acid Pathway—VDR—psoriasis	0.000104	0.00539	CbGpPWpGaD
Spironolactone—Hypersensitivity—Calcitriol—psoriasis	0.000103	0.00229	CcSEcCtD
Spironolactone—PGR—Validated nuclear estrogen receptor alpha network—PCNA—psoriasis	0.000103	0.00534	CbGpPWpGaD
Spironolactone—Feeling abnormal—Acitretin—psoriasis	0.000103	0.00227	CcSEcCtD
Spironolactone—Renal failure—Cyclosporine—psoriasis	0.000102	0.00226	CcSEcCtD
Spironolactone—Alopecia—Mycophenolic acid—psoriasis	0.000102	0.00226	CcSEcCtD
Spironolactone—NR3C1—Nuclear Receptors—VDR—psoriasis	0.000102	0.00528	CbGpPWpGaD
Spironolactone—Discomfort—Hydroxyurea—psoriasis	0.000101	0.00223	CcSEcCtD
Spironolactone—NR3C2—Gene Expression—TARS—psoriasis	0.000101	0.00524	CbGpPWpGaD
Spironolactone—PGR—Cellular roles of Anthrax toxin—TNF—psoriasis	0.000101	0.00523	CbGpPWpGaD
Spironolactone—Renal failure—Mycophenolate mofetil—psoriasis	9.98e-05	0.00221	CcSEcCtD
Spironolactone—Pruritus—Calcitriol—psoriasis	9.92e-05	0.00219	CcSEcCtD
Spironolactone—Rash—Methoxsalen—psoriasis	9.92e-05	0.00219	CcSEcCtD
Spironolactone—Dermatitis—Methoxsalen—psoriasis	9.91e-05	0.00219	CcSEcCtD
Spironolactone—Urticaria—Acitretin—psoriasis	9.91e-05	0.00219	CcSEcCtD
Spironolactone—Body temperature increased—Acitretin—psoriasis	9.87e-05	0.00218	CcSEcCtD
Spironolactone—Headache—Methoxsalen—psoriasis	9.86e-05	0.00218	CcSEcCtD
Spironolactone—Body temperature increased—Fluocinolone Acetonide—psoriasis	9.84e-05	0.00218	CcSEcCtD
Spironolactone—PGR—Nuclear Receptor transcription pathway—PPARG—psoriasis	9.69e-05	0.00503	CbGpPWpGaD
Spironolactone—Muscle spasms—Mycophenolic acid—psoriasis	9.67e-05	0.00214	CcSEcCtD
Spironolactone—Diarrhoea—Calcitriol—psoriasis	9.6e-05	0.00212	CcSEcCtD
Spironolactone—Thrombocytopenia—Hydroxyurea—psoriasis	9.59e-05	0.00212	CcSEcCtD
Spironolactone—Agranulocytosis—Mycophenolate mofetil—psoriasis	9.48e-05	0.0021	CcSEcCtD
Spironolactone—Nausea—Methoxsalen—psoriasis	9.35e-05	0.00207	CcSEcCtD
Spironolactone—AR—Nuclear Receptors—PPARG—psoriasis	9.34e-05	0.00485	CbGpPWpGaD
Spironolactone—Ill-defined disorder—Mycophenolic acid—psoriasis	9.33e-05	0.00206	CcSEcCtD
Spironolactone—Gynaecomastia—Methotrexate—psoriasis	9.2e-05	0.00203	CcSEcCtD
Spironolactone—Hypersensitivity—Acitretin—psoriasis	9.19e-05	0.00203	CcSEcCtD
Spironolactone—Hypersensitivity—Fluocinolone Acetonide—psoriasis	9.17e-05	0.00203	CcSEcCtD
Spironolactone—Lethargy—Prednisone—psoriasis	9.11e-05	0.00202	CcSEcCtD
Spironolactone—Malaise—Mycophenolic acid—psoriasis	9.07e-05	0.00201	CcSEcCtD
Spironolactone—Leukopenia—Mycophenolic acid—psoriasis	9e-05	0.00199	CcSEcCtD
Spironolactone—Vomiting—Calcitriol—psoriasis	8.92e-05	0.00197	CcSEcCtD
Spironolactone—ABCC2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	8.85e-05	0.00459	CbGpPWpGaD
Spironolactone—Rash—Calcitriol—psoriasis	8.84e-05	0.00196	CcSEcCtD
Spironolactone—Dermatitis—Calcitriol—psoriasis	8.84e-05	0.00195	CcSEcCtD
Spironolactone—Pruritus—Acitretin—psoriasis	8.83e-05	0.00195	CcSEcCtD
Spironolactone—Pruritus—Fluocinolone Acetonide—psoriasis	8.8e-05	0.00195	CcSEcCtD
Spironolactone—Headache—Calcitriol—psoriasis	8.79e-05	0.00194	CcSEcCtD
Spironolactone—Somnolence—Hydroxyurea—psoriasis	8.71e-05	0.00193	CcSEcCtD
Spironolactone—NR3C1—Glucocorticoid receptor regulatory network—IL13—psoriasis	8.54e-05	0.00443	CbGpPWpGaD
Spironolactone—Diarrhoea—Acitretin—psoriasis	8.54e-05	0.00189	CcSEcCtD
Spironolactone—AR—SIDS Susceptibility Pathways—RUNX3—psoriasis	8.53e-05	0.00443	CbGpPWpGaD
Spironolactone—Diarrhoea—Fluocinolone Acetonide—psoriasis	8.51e-05	0.00188	CcSEcCtD
Spironolactone—Gastrointestinal disorder—Hydroxyurea—psoriasis	8.46e-05	0.00187	CcSEcCtD
Spironolactone—Discomfort—Mycophenolic acid—psoriasis	8.46e-05	0.00187	CcSEcCtD
Spironolactone—Nausea—Calcitriol—psoriasis	8.33e-05	0.00184	CcSEcCtD
Spironolactone—Confusional state—Mycophenolic acid—psoriasis	8.27e-05	0.00183	CcSEcCtD
Spironolactone—Alopecia—Cyclosporine—psoriasis	8.26e-05	0.00183	CcSEcCtD
Spironolactone—Dizziness—Acitretin—psoriasis	8.25e-05	0.00183	CcSEcCtD
Spironolactone—Dizziness—Fluocinolone Acetonide—psoriasis	8.23e-05	0.00182	CcSEcCtD
Spironolactone—Renal failure acute—Methotrexate—psoriasis	8.08e-05	0.00179	CcSEcCtD
Spironolactone—Feeling abnormal—Hydroxyurea—psoriasis	8.07e-05	0.00179	CcSEcCtD
Spironolactone—Alopecia—Mycophenolate mofetil—psoriasis	8.05e-05	0.00178	CcSEcCtD
Spironolactone—Thrombocytopenia—Mycophenolic acid—psoriasis	8.03e-05	0.00178	CcSEcCtD
Spironolactone—NR3C1—Nuclear Receptor transcription pathway—VDR—psoriasis	8.03e-05	0.00417	CbGpPWpGaD
Spironolactone—AR—Integrated Pancreatic Cancer Pathway—PTTG1—psoriasis	8.02e-05	0.00416	CbGpPWpGaD
Spironolactone—Vomiting—Acitretin—psoriasis	7.93e-05	0.00175	CcSEcCtD
Spironolactone—Vomiting—Fluocinolone Acetonide—psoriasis	7.91e-05	0.00175	CcSEcCtD
Spironolactone—Rash—Acitretin—psoriasis	7.87e-05	0.00174	CcSEcCtD
Spironolactone—Dermatitis—Acitretin—psoriasis	7.86e-05	0.00174	CcSEcCtD
Spironolactone—Rash—Fluocinolone Acetonide—psoriasis	7.85e-05	0.00174	CcSEcCtD
Spironolactone—Dermatitis—Fluocinolone Acetonide—psoriasis	7.84e-05	0.00173	CcSEcCtD
Spironolactone—Muscle spasms—Cyclosporine—psoriasis	7.82e-05	0.00173	CcSEcCtD
Spironolactone—Headache—Acitretin—psoriasis	7.82e-05	0.00173	CcSEcCtD
Spironolactone—Headache—Fluocinolone Acetonide—psoriasis	7.8e-05	0.00172	CcSEcCtD
Spironolactone—Body temperature increased—Hydroxyurea—psoriasis	7.75e-05	0.00171	CcSEcCtD
Spironolactone—Muscle spasms—Mycophenolate mofetil—psoriasis	7.63e-05	0.00169	CcSEcCtD
Spironolactone—Lethargy—Methotrexate—psoriasis	7.62e-05	0.00168	CcSEcCtD
Spironolactone—Ill-defined disorder—Cyclosporine—psoriasis	7.55e-05	0.00167	CcSEcCtD
Spironolactone—CYP11B1—Corticotropin-releasing hormone—NFKBIA—psoriasis	7.48e-05	0.00388	CbGpPWpGaD
Spironolactone—Nausea—Acitretin—psoriasis	7.41e-05	0.00164	CcSEcCtD
Spironolactone—Nausea—Fluocinolone Acetonide—psoriasis	7.39e-05	0.00163	CcSEcCtD
Spironolactone—AR—Nuclear Receptor transcription pathway—PPARG—psoriasis	7.38e-05	0.00383	CbGpPWpGaD
Spironolactone—Ill-defined disorder—Mycophenolate mofetil—psoriasis	7.36e-05	0.00163	CcSEcCtD
Spironolactone—Malaise—Cyclosporine—psoriasis	7.34e-05	0.00162	CcSEcCtD
Spironolactone—AR—Regulation of nuclear SMAD2/3 signaling—VDR—psoriasis	7.31e-05	0.0038	CbGpPWpGaD
Spironolactone—Somnolence—Mycophenolic acid—psoriasis	7.3e-05	0.00161	CcSEcCtD
Spironolactone—Leukopenia—Cyclosporine—psoriasis	7.28e-05	0.00161	CcSEcCtD
Spironolactone—Hypersensitivity—Hydroxyurea—psoriasis	7.22e-05	0.0016	CcSEcCtD
Spironolactone—Malaise—Mycophenolate mofetil—psoriasis	7.16e-05	0.00158	CcSEcCtD
Spironolactone—AR—Regulation of nuclear SMAD2/3 signaling—IL10—psoriasis	7.11e-05	0.00369	CbGpPWpGaD
Spironolactone—Erectile dysfunction—Prednisone—psoriasis	7.11e-05	0.00157	CcSEcCtD
Spironolactone—Leukopenia—Mycophenolate mofetil—psoriasis	7.1e-05	0.00157	CcSEcCtD
Spironolactone—NR3C1—Nuclear Receptors—PPARG—psoriasis	7.09e-05	0.00368	CbGpPWpGaD
Spironolactone—Gastrointestinal disorder—Mycophenolic acid—psoriasis	7.08e-05	0.00157	CcSEcCtD
Spironolactone—Ataxia—Methotrexate—psoriasis	7.02e-05	0.00155	CcSEcCtD
Spironolactone—Ill-defined disorder—Prednisolone—psoriasis	6.87e-05	0.00152	CcSEcCtD
Spironolactone—Discomfort—Cyclosporine—psoriasis	6.84e-05	0.00151	CcSEcCtD
Spironolactone—Feeling abnormal—Mycophenolic acid—psoriasis	6.76e-05	0.0015	CcSEcCtD
Spironolactone—AR—SIDS Susceptibility Pathways—IL13—psoriasis	6.73e-05	0.00349	CbGpPWpGaD
Spironolactone—Toxic epidermal necrolysis—Methotrexate—psoriasis	6.72e-05	0.00149	CcSEcCtD
Spironolactone—Ill-defined disorder—Hydrocortisone—psoriasis	6.71e-05	0.00148	CcSEcCtD
Spironolactone—Diarrhoea—Hydroxyurea—psoriasis	6.7e-05	0.00148	CcSEcCtD
Spironolactone—Confusional state—Cyclosporine—psoriasis	6.69e-05	0.00148	CcSEcCtD
Spironolactone—Malaise—Prednisolone—psoriasis	6.67e-05	0.00148	CcSEcCtD
Spironolactone—Discomfort—Mycophenolate mofetil—psoriasis	6.67e-05	0.00148	CcSEcCtD
Spironolactone—Anaphylactic shock—Cyclosporine—psoriasis	6.64e-05	0.00147	CcSEcCtD
Spironolactone—ABCC2—NRF2 pathway—TGFA—psoriasis	6.63e-05	0.00344	CbGpPWpGaD
Spironolactone—NR3C2—Generic Transcription Pathway—CARM1—psoriasis	6.6e-05	0.00343	CbGpPWpGaD
Spironolactone—Confusional state—Mycophenolate mofetil—psoriasis	6.53e-05	0.00144	CcSEcCtD
Spironolactone—Malaise—Hydrocortisone—psoriasis	6.52e-05	0.00144	CcSEcCtD
Spironolactone—Thrombocytopenia—Cyclosporine—psoriasis	6.5e-05	0.00144	CcSEcCtD
Spironolactone—Body temperature increased—Mycophenolic acid—psoriasis	6.49e-05	0.00143	CcSEcCtD
Spironolactone—Dizziness—Hydroxyurea—psoriasis	6.48e-05	0.00143	CcSEcCtD
Spironolactone—Anaphylactic shock—Mycophenolate mofetil—psoriasis	6.48e-05	0.00143	CcSEcCtD
Spironolactone—NR3C1—SIDS Susceptibility Pathways—RUNX3—psoriasis	6.47e-05	0.00336	CbGpPWpGaD
Spironolactone—CYP2C8—Biological oxidations—CYP2S1—psoriasis	6.42e-05	0.00333	CbGpPWpGaD
Spironolactone—Eosinophilia—Methotrexate—psoriasis	6.39e-05	0.00141	CcSEcCtD
Spironolactone—Thrombocytopenia—Mycophenolate mofetil—psoriasis	6.34e-05	0.0014	CcSEcCtD
Spironolactone—CYP2C8—Metapathway biotransformation—CYP2S1—psoriasis	6.33e-05	0.00329	CbGpPWpGaD
Spironolactone—Ill-defined disorder—Triamcinolone—psoriasis	6.32e-05	0.0014	CcSEcCtD
Spironolactone—Alopecia—Dexamethasone—psoriasis	6.27e-05	0.00139	CcSEcCtD
Spironolactone—Alopecia—Betamethasone—psoriasis	6.27e-05	0.00139	CcSEcCtD
Spironolactone—AR—Notch-mediated HES/HEY network—CD4—psoriasis	6.24e-05	0.00324	CbGpPWpGaD
Spironolactone—Vomiting—Hydroxyurea—psoriasis	6.23e-05	0.00138	CcSEcCtD
Spironolactone—Discomfort—Prednisolone—psoriasis	6.23e-05	0.00138	CcSEcCtD
Spironolactone—Rash—Hydroxyurea—psoriasis	6.18e-05	0.00137	CcSEcCtD
Spironolactone—Dermatitis—Hydroxyurea—psoriasis	6.17e-05	0.00136	CcSEcCtD
Spironolactone—ABCB1—HIF-1-alpha transcription factor network—CP—psoriasis	6.16e-05	0.0032	CbGpPWpGaD
Spironolactone—PGR—Gene Expression—TARS—psoriasis	6.15e-05	0.00319	CbGpPWpGaD
Spironolactone—Malaise—Triamcinolone—psoriasis	6.14e-05	0.00136	CcSEcCtD
Spironolactone—Headache—Hydroxyurea—psoriasis	6.14e-05	0.00136	CcSEcCtD
Spironolactone—Discomfort—Hydrocortisone—psoriasis	6.08e-05	0.00134	CcSEcCtD
Spironolactone—NR3C1—AP-1 transcription factor network—IL10—psoriasis	6.07e-05	0.00315	CbGpPWpGaD
Spironolactone—Anaphylactic shock—Prednisolone—psoriasis	6.04e-05	0.00134	CcSEcCtD
Spironolactone—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	5.97e-05	0.0031	CbGpPWpGaD
Spironolactone—Erectile dysfunction—Methotrexate—psoriasis	5.94e-05	0.00131	CcSEcCtD
Spironolactone—Somnolence—Cyclosporine—psoriasis	5.9e-05	0.00131	CcSEcCtD
Spironolactone—NR3C1—AP-1 transcription factor network—IL4—psoriasis	5.9e-05	0.00306	CbGpPWpGaD
Spironolactone—Anaphylactic shock—Hydrocortisone—psoriasis	5.9e-05	0.0013	CcSEcCtD
Spironolactone—AR—FOXA1 transcription factor network—JUN—psoriasis	5.89e-05	0.00306	CbGpPWpGaD
Spironolactone—NR3C1—Transcription factor regulation in adipogenesis—TNF—psoriasis	5.83e-05	0.00302	CbGpPWpGaD
Spironolactone—Nausea—Hydroxyurea—psoriasis	5.82e-05	0.00129	CcSEcCtD
Spironolactone—Pruritus—Mycophenolic acid—psoriasis	5.81e-05	0.00128	CcSEcCtD
Spironolactone—Somnolence—Mycophenolate mofetil—psoriasis	5.76e-05	0.00127	CcSEcCtD
Spironolactone—Drowsiness—Methotrexate—psoriasis	5.75e-05	0.00127	CcSEcCtD
Spironolactone—Gastrointestinal disorder—Cyclosporine—psoriasis	5.73e-05	0.00127	CcSEcCtD
Spironolactone—Ill-defined disorder—Betamethasone—psoriasis	5.73e-05	0.00127	CcSEcCtD
Spironolactone—Ill-defined disorder—Dexamethasone—psoriasis	5.73e-05	0.00127	CcSEcCtD
Spironolactone—PGR—Validated nuclear estrogen receptor alpha network—JUN—psoriasis	5.73e-05	0.00297	CbGpPWpGaD
Spironolactone—Discomfort—Triamcinolone—psoriasis	5.73e-05	0.00127	CcSEcCtD
Spironolactone—Stevens-Johnson syndrome—Methotrexate—psoriasis	5.7e-05	0.00126	CcSEcCtD
Spironolactone—Renal failure—Methotrexate—psoriasis	5.65e-05	0.00125	CcSEcCtD
Spironolactone—Diarrhoea—Mycophenolic acid—psoriasis	5.61e-05	0.00124	CcSEcCtD
Spironolactone—NR3C1—Nuclear Receptor transcription pathway—PPARG—psoriasis	5.6e-05	0.00291	CbGpPWpGaD
Spironolactone—Gastrointestinal disorder—Mycophenolate mofetil—psoriasis	5.59e-05	0.00124	CcSEcCtD
Spironolactone—Malaise—Betamethasone—psoriasis	5.57e-05	0.00123	CcSEcCtD
Spironolactone—Malaise—Dexamethasone—psoriasis	5.57e-05	0.00123	CcSEcCtD
Spironolactone—Anaphylactic shock—Triamcinolone—psoriasis	5.56e-05	0.00123	CcSEcCtD
Spironolactone—NR3C1—Regulation of nuclear SMAD2/3 signaling—VDR—psoriasis	5.55e-05	0.00288	CbGpPWpGaD
Spironolactone—Feeling abnormal—Cyclosporine—psoriasis	5.47e-05	0.00121	CcSEcCtD
Spironolactone—Alopecia—Prednisone—psoriasis	5.46e-05	0.00121	CcSEcCtD
Spironolactone—Dizziness—Mycophenolic acid—psoriasis	5.43e-05	0.0012	CcSEcCtD
Spironolactone—NR3C1—Regulation of nuclear SMAD2/3 signaling—IL10—psoriasis	5.4e-05	0.0028	CbGpPWpGaD
Spironolactone—Agranulocytosis—Methotrexate—psoriasis	5.37e-05	0.00119	CcSEcCtD
Spironolactone—NR3C1—AP-1 transcription factor network—HLA-A—psoriasis	5.35e-05	0.00277	CbGpPWpGaD
Spironolactone—Feeling abnormal—Mycophenolate mofetil—psoriasis	5.34e-05	0.00118	CcSEcCtD
Spironolactone—CYP11B1—Corticotropin-releasing hormone—CXCL8—psoriasis	5.33e-05	0.00277	CbGpPWpGaD
Spironolactone—Urticaria—Cyclosporine—psoriasis	5.27e-05	0.00117	CcSEcCtD
Spironolactone—Body temperature increased—Cyclosporine—psoriasis	5.25e-05	0.00116	CcSEcCtD
Spironolactone—Vomiting—Mycophenolic acid—psoriasis	5.22e-05	0.00115	CcSEcCtD
Spironolactone—NR3C1—Glucocorticoid receptor regulatory network—IL4—psoriasis	5.2e-05	0.0027	CbGpPWpGaD
Spironolactone—Discomfort—Betamethasone—psoriasis	5.2e-05	0.00115	CcSEcCtD
Spironolactone—Discomfort—Dexamethasone—psoriasis	5.2e-05	0.00115	CcSEcCtD
Spironolactone—Rash—Mycophenolic acid—psoriasis	5.17e-05	0.00114	CcSEcCtD
Spironolactone—Dermatitis—Mycophenolic acid—psoriasis	5.17e-05	0.00114	CcSEcCtD
Spironolactone—Urticaria—Mycophenolate mofetil—psoriasis	5.14e-05	0.00114	CcSEcCtD
Spironolactone—Headache—Mycophenolic acid—psoriasis	5.14e-05	0.00114	CcSEcCtD
Spironolactone—Body temperature increased—Mycophenolate mofetil—psoriasis	5.12e-05	0.00113	CcSEcCtD
Spironolactone—NR3C1—SIDS Susceptibility Pathways—IL13—psoriasis	5.11e-05	0.00265	CbGpPWpGaD
Spironolactone—Gastrointestinal disorder—Hydrocortisone—psoriasis	5.09e-05	0.00113	CcSEcCtD
Spironolactone—AR—Regulation of Androgen receptor activity—JUN—psoriasis	5.08e-05	0.00264	CbGpPWpGaD
Spironolactone—Anaphylactic shock—Dexamethasone—psoriasis	5.04e-05	0.00111	CcSEcCtD
Spironolactone—Anaphylactic shock—Betamethasone—psoriasis	5.04e-05	0.00111	CcSEcCtD
Spironolactone—Ill-defined disorder—Prednisone—psoriasis	4.99e-05	0.0011	CcSEcCtD
Spironolactone—Feeling abnormal—Prednisolone—psoriasis	4.98e-05	0.0011	CcSEcCtD
Spironolactone—Thrombocytopenia—Betamethasone—psoriasis	4.94e-05	0.00109	CcSEcCtD
Spironolactone—Thrombocytopenia—Dexamethasone—psoriasis	4.94e-05	0.00109	CcSEcCtD
Spironolactone—Hypersensitivity—Cyclosporine—psoriasis	4.89e-05	0.00108	CcSEcCtD
Spironolactone—Erythema multiforme—Methotrexate—psoriasis	4.88e-05	0.00108	CcSEcCtD
Spironolactone—Nausea—Mycophenolic acid—psoriasis	4.87e-05	0.00108	CcSEcCtD
Spironolactone—CYP11B2—Metabolism—NDUFA5—psoriasis	4.87e-05	0.00253	CbGpPWpGaD
Spironolactone—Feeling abnormal—Hydrocortisone—psoriasis	4.86e-05	0.00108	CcSEcCtD
Spironolactone—Malaise—Prednisone—psoriasis	4.85e-05	0.00107	CcSEcCtD
Spironolactone—AR—Notch-mediated HES/HEY network—STAT3—psoriasis	4.83e-05	0.00251	CbGpPWpGaD
Spironolactone—SLCO1A2—SLC-mediated transmembrane transport—CP—psoriasis	4.81e-05	0.0025	CbGpPWpGaD
Spironolactone—Urticaria—Prednisolone—psoriasis	4.8e-05	0.00106	CcSEcCtD
Spironolactone—CYP11B1—Corticotropin-releasing hormone—NFKB1—psoriasis	4.77e-05	0.00248	CbGpPWpGaD
Spironolactone—Hypersensitivity—Mycophenolate mofetil—psoriasis	4.77e-05	0.00106	CcSEcCtD
Spironolactone—ABCB1—Allograft Rejection—HLA-C—psoriasis	4.76e-05	0.00247	CbGpPWpGaD
Spironolactone—ABCB1—Allograft Rejection—IL13—psoriasis	4.73e-05	0.00245	CbGpPWpGaD
Spironolactone—NR3C1—Transcription factor regulation in adipogenesis—IL6—psoriasis	4.7e-05	0.00244	CbGpPWpGaD
Spironolactone—Pruritus—Cyclosporine—psoriasis	4.7e-05	0.00104	CcSEcCtD
Spironolactone—Urticaria—Hydrocortisone—psoriasis	4.69e-05	0.00104	CcSEcCtD
Spironolactone—AR—Gene Expression—TARS—psoriasis	4.69e-05	0.00243	CbGpPWpGaD
Spironolactone—Body temperature increased—Hydrocortisone—psoriasis	4.66e-05	0.00103	CcSEcCtD
Spironolactone—Pruritus—Mycophenolate mofetil—psoriasis	4.58e-05	0.00101	CcSEcCtD
Spironolactone—Feeling abnormal—Triamcinolone—psoriasis	4.58e-05	0.00101	CcSEcCtD
Spironolactone—Alopecia—Methotrexate—psoriasis	4.56e-05	0.00101	CcSEcCtD
Spironolactone—Diarrhoea—Cyclosporine—psoriasis	4.54e-05	0.001	CcSEcCtD
Spironolactone—CYP11B2—Metabolism of lipids and lipoproteins—CARM1—psoriasis	4.54e-05	0.00235	CbGpPWpGaD
Spironolactone—Discomfort—Prednisone—psoriasis	4.52e-05	0.001	CcSEcCtD
Spironolactone—Hypersensitivity—Prednisolone—psoriasis	4.45e-05	0.000984	CcSEcCtD
Spironolactone—Diarrhoea—Mycophenolate mofetil—psoriasis	4.43e-05	0.00098	CcSEcCtD
Spironolactone—Urticaria—Triamcinolone—psoriasis	4.41e-05	0.000976	CcSEcCtD
Spironolactone—Body temperature increased—Triamcinolone—psoriasis	4.39e-05	0.000971	CcSEcCtD
Spironolactone—Dizziness—Cyclosporine—psoriasis	4.39e-05	0.000971	CcSEcCtD
Spironolactone—Anaphylactic shock—Prednisone—psoriasis	4.39e-05	0.000971	CcSEcCtD
Spironolactone—Gastrointestinal disorder—Betamethasone—psoriasis	4.35e-05	0.000962	CcSEcCtD
Spironolactone—Gastrointestinal disorder—Dexamethasone—psoriasis	4.35e-05	0.000962	CcSEcCtD
Spironolactone—ABCB1—Allograft Rejection—IL17A—psoriasis	4.35e-05	0.00226	CbGpPWpGaD
Spironolactone—Hypersensitivity—Hydrocortisone—psoriasis	4.35e-05	0.000961	CcSEcCtD
Spironolactone—Dizziness—Mycophenolate mofetil—psoriasis	4.28e-05	0.000947	CcSEcCtD
Spironolactone—Vomiting—Cyclosporine—psoriasis	4.22e-05	0.000933	CcSEcCtD
Spironolactone—AR—SIDS Susceptibility Pathways—IL10—psoriasis	4.21e-05	0.00219	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—NDUFA5—psoriasis	4.19e-05	0.00218	CbGpPWpGaD
Spironolactone—Rash—Cyclosporine—psoriasis	4.19e-05	0.000926	CcSEcCtD
Spironolactone—Dermatitis—Cyclosporine—psoriasis	4.18e-05	0.000925	CcSEcCtD
Spironolactone—Pruritus—Hydrocortisone—psoriasis	4.17e-05	0.000923	CcSEcCtD
Spironolactone—Ill-defined disorder—Methotrexate—psoriasis	4.17e-05	0.000922	CcSEcCtD
Spironolactone—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	4.16e-05	0.00216	CbGpPWpGaD
Spironolactone—Headache—Cyclosporine—psoriasis	4.16e-05	0.00092	CcSEcCtD
Spironolactone—Feeling abnormal—Betamethasone—psoriasis	4.15e-05	0.000919	CcSEcCtD
Spironolactone—Feeling abnormal—Dexamethasone—psoriasis	4.15e-05	0.000919	CcSEcCtD
Spironolactone—CYP11B2—Metabolism—CYP2S1—psoriasis	4.14e-05	0.00215	CbGpPWpGaD
Spironolactone—NR3C1—Glucocorticoid receptor regulatory network—ICAM1—psoriasis	4.13e-05	0.00214	CbGpPWpGaD
Spironolactone—NR3C1—Adipogenesis—SOCS1—psoriasis	4.12e-05	0.00214	CbGpPWpGaD
Spironolactone—Vomiting—Mycophenolate mofetil—psoriasis	4.12e-05	0.000911	CcSEcCtD
Spironolactone—Hypersensitivity—Triamcinolone—psoriasis	4.09e-05	0.000905	CcSEcCtD
Spironolactone—Rash—Mycophenolate mofetil—psoriasis	4.08e-05	0.000903	CcSEcCtD
Spironolactone—Dermatitis—Mycophenolate mofetil—psoriasis	4.08e-05	0.000902	CcSEcCtD
Spironolactone—Headache—Mycophenolate mofetil—psoriasis	4.06e-05	0.000897	CcSEcCtD
Spironolactone—Malaise—Methotrexate—psoriasis	4.05e-05	0.000897	CcSEcCtD
Spironolactone—ABCB1—Allograft Rejection—IL12B—psoriasis	4.05e-05	0.0021	CbGpPWpGaD
Spironolactone—Diarrhoea—Hydrocortisone—psoriasis	4.04e-05	0.000893	CcSEcCtD
Spironolactone—Leukopenia—Methotrexate—psoriasis	4.02e-05	0.00089	CcSEcCtD
Spironolactone—PGR—Generic Transcription Pathway—CARM1—psoriasis	4.02e-05	0.00209	CbGpPWpGaD
Spironolactone—Urticaria—Betamethasone—psoriasis	4e-05	0.000886	CcSEcCtD
Spironolactone—Urticaria—Dexamethasone—psoriasis	4e-05	0.000886	CcSEcCtD
Spironolactone—Dizziness—Prednisolone—psoriasis	3.99e-05	0.000883	CcSEcCtD
Spironolactone—Body temperature increased—Betamethasone—psoriasis	3.98e-05	0.000881	CcSEcCtD
Spironolactone—Body temperature increased—Dexamethasone—psoriasis	3.98e-05	0.000881	CcSEcCtD
Spironolactone—ABCB1—Allograft Rejection—HLA-E—psoriasis	3.95e-05	0.00205	CbGpPWpGaD
Spironolactone—Nausea—Cyclosporine—psoriasis	3.94e-05	0.000872	CcSEcCtD
Spironolactone—NR3C2—Generic Transcription Pathway—VDR—psoriasis	3.94e-05	0.00205	CbGpPWpGaD
Spironolactone—Pruritus—Triamcinolone—psoriasis	3.93e-05	0.000869	CcSEcCtD
Spironolactone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CXCL8—psoriasis	3.93e-05	0.00204	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism of lipids and lipoproteins—CARM1—psoriasis	3.91e-05	0.00203	CbGpPWpGaD
Spironolactone—Dizziness—Hydrocortisone—psoriasis	3.9e-05	0.000863	CcSEcCtD
Spironolactone—NR3C1—Regulation of Androgen receptor activity—JUN—psoriasis	3.85e-05	0.002	CbGpPWpGaD
Spironolactone—Nausea—Mycophenolate mofetil—psoriasis	3.85e-05	0.000851	CcSEcCtD
Spironolactone—Rash—Prednisolone—psoriasis	3.81e-05	0.000842	CcSEcCtD
Spironolactone—Dermatitis—Prednisolone—psoriasis	3.81e-05	0.000842	CcSEcCtD
Spironolactone—Headache—Prednisolone—psoriasis	3.78e-05	0.000837	CcSEcCtD
Spironolactone—Discomfort—Methotrexate—psoriasis	3.78e-05	0.000836	CcSEcCtD
Spironolactone—Vomiting—Hydrocortisone—psoriasis	3.75e-05	0.00083	CcSEcCtD
Spironolactone—Rash—Hydrocortisone—psoriasis	3.72e-05	0.000823	CcSEcCtD
Spironolactone—Dermatitis—Hydrocortisone—psoriasis	3.72e-05	0.000822	CcSEcCtD
Spironolactone—Confusional state—Methotrexate—psoriasis	3.7e-05	0.000818	CcSEcCtD
Spironolactone—Headache—Hydrocortisone—psoriasis	3.7e-05	0.000817	CcSEcCtD
Spironolactone—Dizziness—Triamcinolone—psoriasis	3.67e-05	0.000812	CcSEcCtD
Spironolactone—Anaphylactic shock—Methotrexate—psoriasis	3.67e-05	0.000811	CcSEcCtD
Spironolactone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—JUN—psoriasis	3.65e-05	0.0019	CbGpPWpGaD
Spironolactone—Feeling abnormal—Prednisone—psoriasis	3.62e-05	0.0008	CcSEcCtD
Spironolactone—AR—Regulation of nuclear SMAD2/3 signaling—JUN—psoriasis	3.62e-05	0.00188	CbGpPWpGaD
Spironolactone—Thrombocytopenia—Methotrexate—psoriasis	3.59e-05	0.000794	CcSEcCtD
Spironolactone—Nausea—Prednisolone—psoriasis	3.59e-05	0.000794	CcSEcCtD
Spironolactone—NR3C1—AP-1 transcription factor network—IFNG—psoriasis	3.57e-05	0.00185	CbGpPWpGaD
Spironolactone—Pruritus—Dexamethasone—psoriasis	3.57e-05	0.000789	CcSEcCtD
Spironolactone—Pruritus—Betamethasone—psoriasis	3.57e-05	0.000789	CcSEcCtD
Spironolactone—CYP11B1—Metabolism—CYP2S1—psoriasis	3.56e-05	0.00185	CbGpPWpGaD
Spironolactone—NR3C1—Gene Expression—TARS—psoriasis	3.55e-05	0.00185	CbGpPWpGaD
Spironolactone—PGR—Signaling by ERBB4—TYK2—psoriasis	3.54e-05	0.00184	CbGpPWpGaD
Spironolactone—Vomiting—Triamcinolone—psoriasis	3.53e-05	0.000781	CcSEcCtD
Spironolactone—Nausea—Hydrocortisone—psoriasis	3.5e-05	0.000775	CcSEcCtD
Spironolactone—Rash—Triamcinolone—psoriasis	3.5e-05	0.000775	CcSEcCtD
Spironolactone—Dermatitis—Triamcinolone—psoriasis	3.5e-05	0.000774	CcSEcCtD
Spironolactone—Urticaria—Prednisone—psoriasis	3.49e-05	0.000771	CcSEcCtD
Spironolactone—Headache—Triamcinolone—psoriasis	3.48e-05	0.00077	CcSEcCtD
Spironolactone—Body temperature increased—Prednisone—psoriasis	3.47e-05	0.000767	CcSEcCtD
Spironolactone—Diarrhoea—Dexamethasone—psoriasis	3.45e-05	0.000763	CcSEcCtD
Spironolactone—Diarrhoea—Betamethasone—psoriasis	3.45e-05	0.000763	CcSEcCtD
Spironolactone—AR—Androgen receptor signaling pathway—JUN—psoriasis	3.35e-05	0.00174	CbGpPWpGaD
Spironolactone—Dizziness—Betamethasone—psoriasis	3.33e-05	0.000737	CcSEcCtD
Spironolactone—Dizziness—Dexamethasone—psoriasis	3.33e-05	0.000737	CcSEcCtD
Spironolactone—NR3C1—AP-1 transcription factor network—CXCL8—psoriasis	3.32e-05	0.00172	CbGpPWpGaD
Spironolactone—Nausea—Triamcinolone—psoriasis	3.3e-05	0.00073	CcSEcCtD
Spironolactone—AR—Integrated Pancreatic Cancer Pathway—PCNA—psoriasis	3.27e-05	0.0017	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—PTTG1—psoriasis	3.27e-05	0.0017	CbGpPWpGaD
Spironolactone—Somnolence—Methotrexate—psoriasis	3.26e-05	0.000721	CcSEcCtD
Spironolactone—Hypersensitivity—Prednisone—psoriasis	3.23e-05	0.000715	CcSEcCtD
Spironolactone—Vomiting—Betamethasone—psoriasis	3.2e-05	0.000709	CcSEcCtD
Spironolactone—Vomiting—Dexamethasone—psoriasis	3.2e-05	0.000709	CcSEcCtD
Spironolactone—NR3C1—SIDS Susceptibility Pathways—IL10—psoriasis	3.19e-05	0.00166	CbGpPWpGaD
Spironolactone—Rash—Betamethasone—psoriasis	3.18e-05	0.000703	CcSEcCtD
Spironolactone—Rash—Dexamethasone—psoriasis	3.18e-05	0.000703	CcSEcCtD
Spironolactone—NR3C2—Gene Expression—CARM1—psoriasis	3.18e-05	0.00165	CbGpPWpGaD
Spironolactone—Dermatitis—Dexamethasone—psoriasis	3.18e-05	0.000702	CcSEcCtD
Spironolactone—Dermatitis—Betamethasone—psoriasis	3.18e-05	0.000702	CcSEcCtD
Spironolactone—Gastrointestinal disorder—Methotrexate—psoriasis	3.17e-05	0.0007	CcSEcCtD
Spironolactone—Headache—Dexamethasone—psoriasis	3.16e-05	0.000698	CcSEcCtD
Spironolactone—Headache—Betamethasone—psoriasis	3.16e-05	0.000698	CcSEcCtD
Spironolactone—NR3C1—Glucocorticoid receptor regulatory network—IFNG—psoriasis	3.14e-05	0.00163	CbGpPWpGaD
Spironolactone—Pruritus—Prednisone—psoriasis	3.11e-05	0.000687	CcSEcCtD
Spironolactone—NR3C1—AP-1 transcription factor network—JUN—psoriasis	3.08e-05	0.0016	CbGpPWpGaD
Spironolactone—AR—Generic Transcription Pathway—CARM1—psoriasis	3.06e-05	0.00159	CbGpPWpGaD
Spironolactone—NR3C1—Adipogenesis—LEP—psoriasis	3.04e-05	0.00158	CbGpPWpGaD
Spironolactone—Feeling abnormal—Methotrexate—psoriasis	3.02e-05	0.000669	CcSEcCtD
Spironolactone—Diarrhoea—Prednisone—psoriasis	3e-05	0.000664	CcSEcCtD
Spironolactone—Nausea—Dexamethasone—psoriasis	2.99e-05	0.000662	CcSEcCtD
Spironolactone—Nausea—Betamethasone—psoriasis	2.99e-05	0.000662	CcSEcCtD
Spironolactone—ABCB1—Allograft Rejection—IL10—psoriasis	2.96e-05	0.00154	CbGpPWpGaD
Spironolactone—NR3C1—Glucocorticoid receptor regulatory network—CXCL8—psoriasis	2.92e-05	0.00152	CbGpPWpGaD
Spironolactone—Urticaria—Methotrexate—psoriasis	2.91e-05	0.000645	CcSEcCtD
Spironolactone—Dizziness—Prednisone—psoriasis	2.9e-05	0.000642	CcSEcCtD
Spironolactone—AR—Androgen receptor signaling pathway—STAT3—psoriasis	2.9e-05	0.00151	CbGpPWpGaD
Spironolactone—Body temperature increased—Methotrexate—psoriasis	2.9e-05	0.000641	CcSEcCtD
Spironolactone—ABCB1—Allograft Rejection—IL4—psoriasis	2.88e-05	0.00149	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—HCAR2—psoriasis	2.85e-05	0.00148	CbGpPWpGaD
Spironolactone—ABCB1—Allograft Rejection—HLA-B—psoriasis	2.81e-05	0.00146	CbGpPWpGaD
Spironolactone—ABCB1—HIF-1-alpha transcription factor network—LEP—psoriasis	2.81e-05	0.00146	CbGpPWpGaD
Spironolactone—Vomiting—Prednisone—psoriasis	2.79e-05	0.000617	CcSEcCtD
Spironolactone—Rash—Prednisone—psoriasis	2.77e-05	0.000612	CcSEcCtD
Spironolactone—Dermatitis—Prednisone—psoriasis	2.77e-05	0.000612	CcSEcCtD
Spironolactone—Headache—Prednisone—psoriasis	2.75e-05	0.000608	CcSEcCtD
Spironolactone—NR3C2—Generic Transcription Pathway—PPARG—psoriasis	2.75e-05	0.00143	CbGpPWpGaD
Spironolactone—AR—Integrated Pancreatic Cancer Pathway—NFKBIA—psoriasis	2.75e-05	0.00143	CbGpPWpGaD
Spironolactone—NR3C1—Regulation of nuclear SMAD2/3 signaling—JUN—psoriasis	2.74e-05	0.00142	CbGpPWpGaD
Spironolactone—NR3C1—Glucocorticoid receptor regulatory network—JUN—psoriasis	2.72e-05	0.00141	CbGpPWpGaD
Spironolactone—Hypersensitivity—Methotrexate—psoriasis	2.7e-05	0.000598	CcSEcCtD
Spironolactone—NR3C1—Adipogenesis—PPARG—psoriasis	2.65e-05	0.00138	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—NDUFA5—psoriasis	2.63e-05	0.00136	CbGpPWpGaD
Spironolactone—ABCB1—HIF-1-alpha transcription factor network—NOS2—psoriasis	2.62e-05	0.00136	CbGpPWpGaD
Spironolactone—NR3C1—Glucocorticoid receptor regulatory network—NFKB1—psoriasis	2.61e-05	0.00136	CbGpPWpGaD
Spironolactone—Nausea—Prednisone—psoriasis	2.61e-05	0.000577	CcSEcCtD
Spironolactone—ABCB1—Allograft Rejection—HLA-A—psoriasis	2.61e-05	0.00135	CbGpPWpGaD
Spironolactone—Pruritus—Methotrexate—psoriasis	2.6e-05	0.000574	CcSEcCtD
Spironolactone—Diarrhoea—Methotrexate—psoriasis	2.51e-05	0.000555	CcSEcCtD
Spironolactone—PGR—Signaling Pathways—TAGAP—psoriasis	2.47e-05	0.00128	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism of lipids and lipoproteins—CARM1—psoriasis	2.45e-05	0.00127	CbGpPWpGaD
Spironolactone—SLCO1A2—Transmembrane transport of small molecules—CP—psoriasis	2.44e-05	0.00127	CbGpPWpGaD
Spironolactone—Dizziness—Methotrexate—psoriasis	2.43e-05	0.000537	CcSEcCtD
Spironolactone—PGR—Generic Transcription Pathway—VDR—psoriasis	2.4e-05	0.00125	CbGpPWpGaD
Spironolactone—ABCB1—Allograft Rejection—HLA-DRB1—psoriasis	2.38e-05	0.00124	CbGpPWpGaD
Spironolactone—Vomiting—Methotrexate—psoriasis	2.33e-05	0.000516	CcSEcCtD
Spironolactone—SLCO1A2—Transmembrane transport of small molecules—CARM1—psoriasis	2.33e-05	0.00121	CbGpPWpGaD
Spironolactone—NR3C1—Generic Transcription Pathway—CARM1—psoriasis	2.32e-05	0.00121	CbGpPWpGaD
Spironolactone—Rash—Methotrexate—psoriasis	2.31e-05	0.000512	CcSEcCtD
Spironolactone—Dermatitis—Methotrexate—psoriasis	2.31e-05	0.000511	CcSEcCtD
Spironolactone—AR—SIDS Susceptibility Pathways—CXCL8—psoriasis	2.3e-05	0.0012	CbGpPWpGaD
Spironolactone—Headache—Methotrexate—psoriasis	2.3e-05	0.000508	CcSEcCtD
Spironolactone—SLCO1A2—Metabolism—CYP2S1—psoriasis	2.24e-05	0.00116	CbGpPWpGaD
Spironolactone—ABCC2—Transmembrane transport of small molecules—CP—psoriasis	2.22e-05	0.00115	CbGpPWpGaD
Spironolactone—AR—Integrated Breast Cancer Pathway—JUN—psoriasis	2.2e-05	0.00114	CbGpPWpGaD
Spironolactone—Nausea—Methotrexate—psoriasis	2.18e-05	0.000482	CcSEcCtD
Spironolactone—CYP11B2—Metabolism of lipids and lipoproteins—APOE—psoriasis	2.17e-05	0.00113	CbGpPWpGaD
Spironolactone—AR—SIDS Susceptibility Pathways—JUN—psoriasis	2.14e-05	0.00111	CbGpPWpGaD
Spironolactone—ABCC2—Transmembrane transport of small molecules—CARM1—psoriasis	2.12e-05	0.0011	CbGpPWpGaD
Spironolactone—AR—Integrated Breast Cancer Pathway—NFKB1—psoriasis	2.11e-05	0.0011	CbGpPWpGaD
Spironolactone—AR—SIDS Susceptibility Pathways—NFKB1—psoriasis	2.06e-05	0.00107	CbGpPWpGaD
Spironolactone—NR3C1—AP-1 transcription factor network—TP53—psoriasis	2.04e-05	0.00106	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism—CARM1—psoriasis	2.02e-05	0.00105	CbGpPWpGaD
Spironolactone—PGR—Gene Expression—CARM1—psoriasis	1.94e-05	0.001	CbGpPWpGaD
Spironolactone—AR—Integrated Breast Cancer Pathway—VEGFA—psoriasis	1.92e-05	0.000996	CbGpPWpGaD
Spironolactone—NR3C2—Gene Expression—VDR—psoriasis	1.9e-05	0.000985	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism of lipids and lipoproteins—PPARG—psoriasis	1.89e-05	0.00098	CbGpPWpGaD
Spironolactone—AR—SIDS Susceptibility Pathways—VEGFA—psoriasis	1.87e-05	0.000971	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism of lipids and lipoproteins—APOE—psoriasis	1.87e-05	0.00097	CbGpPWpGaD
Spironolactone—NR3C1—AP-1 transcription factor network—IL6—psoriasis	1.86e-05	0.000967	CbGpPWpGaD
Spironolactone—AR—Generic Transcription Pathway—VDR—psoriasis	1.83e-05	0.000949	CbGpPWpGaD
Spironolactone—AR—Integrated Pancreatic Cancer Pathway—JUN—psoriasis	1.82e-05	0.000945	CbGpPWpGaD
Spironolactone—NR3C1—Glucocorticoid receptor regulatory network—TP53—psoriasis	1.79e-05	0.000931	CbGpPWpGaD
Spironolactone—AR—Integrated Pancreatic Cancer Pathway—NFKB1—psoriasis	1.75e-05	0.00091	CbGpPWpGaD
Spironolactone—NR3C1—SIDS Susceptibility Pathways—CXCL8—psoriasis	1.75e-05	0.000907	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—CARM1—psoriasis	1.74e-05	0.000904	CbGpPWpGaD
Spironolactone—ABCB1—Allograft Rejection—IFNG—psoriasis	1.74e-05	0.000903	CbGpPWpGaD
Spironolactone—ABCB1—HIF-1-alpha transcription factor network—JUN—psoriasis	1.74e-05	0.000901	CbGpPWpGaD
Spironolactone—PGR—Signaling by ERBB4—IL6—psoriasis	1.73e-05	0.0009	CbGpPWpGaD
Spironolactone—PGR—Generic Transcription Pathway—PPARG—psoriasis	1.67e-05	0.000869	CbGpPWpGaD
Spironolactone—NR3C1—Glucocorticoid receptor regulatory network—IL6—psoriasis	1.64e-05	0.000852	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism of lipids and lipoproteins—PPARG—psoriasis	1.63e-05	0.000845	CbGpPWpGaD
Spironolactone—NR3C1—Adipogenesis—STAT3—psoriasis	1.63e-05	0.000844	CbGpPWpGaD
Spironolactone—NR3C1—SIDS Susceptibility Pathways—JUN—psoriasis	1.62e-05	0.000843	CbGpPWpGaD
Spironolactone—ABCB1—Allograft Rejection—CXCL8—psoriasis	1.62e-05	0.00084	CbGpPWpGaD
Spironolactone—AR—SIDS Susceptibility Pathways—TNF—psoriasis	1.6e-05	0.000832	CbGpPWpGaD
Spironolactone—AR—Integrated Pancreatic Cancer Pathway—VEGFA—psoriasis	1.59e-05	0.000826	CbGpPWpGaD
Spironolactone—NR3C1—SIDS Susceptibility Pathways—NFKB1—psoriasis	1.56e-05	0.000811	CbGpPWpGaD
Spironolactone—ABCB1—HIF-1-alpha transcription factor network—VEGFA—psoriasis	1.52e-05	0.000787	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—CCL20—psoriasis	1.48e-05	0.000768	CbGpPWpGaD
Spironolactone—AR—Gene Expression—CARM1—psoriasis	1.47e-05	0.000765	CbGpPWpGaD
Spironolactone—AR—Integrated Breast Cancer Pathway—TP53—psoriasis	1.45e-05	0.000753	CbGpPWpGaD
Spironolactone—NR3C1—SIDS Susceptibility Pathways—VEGFA—psoriasis	1.42e-05	0.000736	CbGpPWpGaD
Spironolactone—NR3C1—Adipogenesis—TNF—psoriasis	1.41e-05	0.00073	CbGpPWpGaD
Spironolactone—NR3C1—Generic Transcription Pathway—VDR—psoriasis	1.39e-05	0.00072	CbGpPWpGaD
Spironolactone—AR—Integrated Pancreatic Cancer Pathway—TNF—psoriasis	1.36e-05	0.000708	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—PCNA—psoriasis	1.33e-05	0.000691	CbGpPWpGaD
Spironolactone—NR3C2—Gene Expression—PPARG—psoriasis	1.32e-05	0.000687	CbGpPWpGaD
Spironolactone—ABCB1—Allograft Rejection—VEGFA—psoriasis	1.31e-05	0.000682	CbGpPWpGaD
Spironolactone—AR—SIDS Susceptibility Pathways—IL6—psoriasis	1.29e-05	0.000671	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—NDUFA5—psoriasis	1.29e-05	0.000671	CbGpPWpGaD
Spironolactone—AR—Generic Transcription Pathway—PPARG—psoriasis	1.27e-05	0.000662	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism—CAT—psoriasis	1.24e-05	0.000645	CbGpPWpGaD
Spironolactone—NR3C1—SIDS Susceptibility Pathways—TNF—psoriasis	1.22e-05	0.000631	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism of lipids and lipoproteins—CARM1—psoriasis	1.2e-05	0.000625	CbGpPWpGaD
Spironolactone—AR—Integrated Pancreatic Cancer Pathway—TP53—psoriasis	1.2e-05	0.000624	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism of lipids and lipoproteins—APOE—psoriasis	1.17e-05	0.000608	CbGpPWpGaD
Spironolactone—PGR—Gene Expression—VDR—psoriasis	1.16e-05	0.0006	CbGpPWpGaD
Spironolactone—NR3C1—Adipogenesis—IL6—psoriasis	1.14e-05	0.000589	CbGpPWpGaD
Spironolactone—ABCB1—Allograft Rejection—TNF—psoriasis	1.13e-05	0.000584	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—NDUFA5—psoriasis	1.13e-05	0.000584	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—NFKBIA—psoriasis	1.12e-05	0.000581	CbGpPWpGaD
Spironolactone—NR3C1—Gene Expression—CARM1—psoriasis	1.12e-05	0.000581	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—CYP2S1—psoriasis	1.1e-05	0.00057	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—CARM1—psoriasis	1.09e-05	0.000567	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—CAT—psoriasis	1.07e-05	0.000556	CbGpPWpGaD
Spironolactone—ABCB1—Transmembrane transport of small molecules—CP—psoriasis	1.05e-05	0.000543	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism of lipids and lipoproteins—PPARG—psoriasis	1.02e-05	0.00053	CbGpPWpGaD
Spironolactone—ABCB1—Transmembrane transport of small molecules—CARM1—psoriasis	9.98e-06	0.000518	CbGpPWpGaD
Spironolactone—NR3C1—SIDS Susceptibility Pathways—IL6—psoriasis	9.81e-06	0.000509	CbGpPWpGaD
Spironolactone—NR3C1—Generic Transcription Pathway—PPARG—psoriasis	9.67e-06	0.000502	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism—APOE—psoriasis	9.65e-06	0.000501	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—CYP2S1—psoriasis	9.57e-06	0.000497	CbGpPWpGaD
Spironolactone—AR—Gene Expression—VDR—psoriasis	8.8e-06	0.000457	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism—PPARG—psoriasis	8.41e-06	0.000437	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—APOE—psoriasis	8.32e-06	0.000432	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—SOCS1—psoriasis	8.15e-06	0.000423	CbGpPWpGaD
Spironolactone—PGR—Gene Expression—PPARG—psoriasis	8.06e-06	0.000418	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—psoriasis	7.42e-06	0.000385	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—PPARG—psoriasis	7.25e-06	0.000376	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—psoriasis	7.14e-06	0.000371	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—CAT—psoriasis	6.71e-06	0.000349	CbGpPWpGaD
Spironolactone—NR3C1—Gene Expression—VDR—psoriasis	6.68e-06	0.000347	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—psoriasis	6.48e-06	0.000336	CbGpPWpGaD
Spironolactone—AR—Gene Expression—PPARG—psoriasis	6.14e-06	0.000319	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—APOE—psoriasis	6.01e-06	0.000312	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—LEP—psoriasis	6.01e-06	0.000312	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism of lipids and lipoproteins—APOE—psoriasis	5.76e-06	0.000299	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—NFKBIA—psoriasis	5.6e-06	0.000291	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—psoriasis	5.56e-06	0.000288	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—CARM1—psoriasis	5.36e-06	0.000278	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—APOE—psoriasis	5.22e-06	0.000271	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—psoriasis	5.01e-06	0.00026	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—psoriasis	4.9e-06	0.000254	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—CARM1—psoriasis	4.67e-06	0.000243	CbGpPWpGaD
Spironolactone—NR3C1—Gene Expression—PPARG—psoriasis	4.66e-06	0.000242	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—TYK2—psoriasis	4.59e-06	0.000238	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—PPARG—psoriasis	4.54e-06	0.000236	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—CXCL8—psoriasis	4e-06	0.000207	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—JUN—psoriasis	3.72e-06	0.000193	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—NFKB1—psoriasis	3.58e-06	0.000186	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—CAT—psoriasis	3.3e-06	0.000171	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—VEGFA—psoriasis	3.25e-06	0.000168	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—STAT3—psoriasis	3.21e-06	0.000167	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—CAT—psoriasis	2.87e-06	0.000149	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—APOE—psoriasis	2.56e-06	0.000133	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—TP53—psoriasis	2.45e-06	0.000127	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—IL6—psoriasis	2.24e-06	0.000117	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—APOE—psoriasis	2.23e-06	0.000116	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—PPARG—psoriasis	2.23e-06	0.000116	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—PPARG—psoriasis	1.95e-06	0.000101	CbGpPWpGaD
